Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.7513
+0.0013 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7400
-0.0113 (-1.50%)
After-hours: Sep 18, 2026, 7:05 PM EDT
Akso Health Group Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
| 644 | 1,953 | 955 | 425 | 178 | 170 | 24 | 8 | 21 | 39 | 36 | |
Market Cap Growth (YoY) | -34.84% | 359.39% | 435.95% | 150.55% | 633.49% | 1990.59% | 17.04% | -78.99% | -43.11% | 28.42% | 52.37% |
Enterprise Value | 646 | 1,944 | 781 | 341 | 95 | 171 | 26 | 8 | 17 | 35 | 34 |
Last Close Price | 0.75 | 2.28 | 1.73 | 1.18 | 1.07 | 1.16 | 1.04 | 0.35 | 0.91 | 1.69 | 2.24 |
Price Ratios
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | 25.61 | - | - |
Forward PE | - | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 |
PS Ratio | 46.53 | 141.22 | 64.32 | 28.77 | 21.07 | 70.29 | 10.95 | 0.62 | 1.75 | - | 56.32 |
PB Ratio | 3.56 | 10.80 | 4.81 | 2.13 | 0.89 | 1.23 | 4.56 | 0.92 | 2.09 | 3.15 | 1.87 |
P/TBV Ratio | 3.56 | 10.80 | 5.29 | 2.36 | 2.02 | 1.23 | 4.65 | 0.93 | 2.09 | 3.15 | 1.87 |
P/FCF Ratio | - | -152.68 | - | 415.76 | - | 125.59 | -14.48 | - | - | - | - |
P/OCF Ratio | - | - | 131.57 | 361.20 | - | 125.59 | -14.48 | - | - | - | 44.23 |
PEG Ratio | - | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
EV Ratios
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 46.69 | 140.56 | 52.59 | 23.05 | 11.24 | 70.65 | 11.80 | 0.59 | 1.46 | - | 52.99 |
EV/FCF Ratio | - | -151.98 | - | 333.10 | - | 126.24 | -15.60 | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 1.88 | 1.10 | 0.98 | 3.03 | 0.61 |
Debt / FCF Ratio | - | -0.19 | - | 2.04 | - | 1.48 | -5.98 | - | - | - | - |
Net Debt / Equity Ratio | 0.01 | 0.01 | -0.05 | -0.87 | -0.42 | -0.60 | 0.14 | 0.20 | -0.03 | 1.53 | -0.18 |
Net Debt / EBITDA Ratio | -1.35 | -1.35 | 6.20 | 98.21 | 161.55 | - | - | -0.12 | 1.48 | - | 0.17 |
Net Debt / FCF Ratio | -0.17 | -0.17 | 0.05 | -170.28 | 21.88 | -61.55 | -0.46 | -0.54 | 0.23 | - | 0.37 |
Return on Capital Employed (ROCE) | -2.20% | -2.20% | -2.40% | -2.00% | -3.40% | -6.20% | -306.90% | -161.40% | -2.20% | - | -99.90% |
Yields
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | -2.90% | -0.96% | -14.21% | -31.75% | -3.70% | -5.57% | -23.17% | -16.75% | 3.91% | - | -55.26% |
FCF Yield | -1.99% | -0.66% | -17.64% | 0.24% | -2.17% | 0.80% | -6.91% | -40.08% | -6.43% | - | -25.57% |
Buyback Yield / Dilution | -153.50% | -153.97% | -152.81% | -371.72% | -919.05% | -212.60% | - | - | -35.37% | - | -3.61% |